Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia — Stella

Home/Cervical Intraepithelial Neoplasia/

View on ClinicalTrials.gov

Recruiting

Back to Cervical Intraepithelial Neoplasia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles, California

Key details

Phase

Safety & dosing

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

Merck Sharp & Dohme LLC

Enrollment target

~25 participants

Started

June 2021

Primary completion

January 2027

Age range

21 Years and older

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.